Elliott Lever

575 total citations
18 papers, 336 citations indexed

About

Elliott Lever is a scholar working on Rheumatology, Oncology and Molecular Biology. According to data from OpenAlex, Elliott Lever has authored 18 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Elliott Lever's work include Systemic Lupus Erythematosus Research (5 papers), Genomics and Chromatin Dynamics (3 papers) and COVID-19 and healthcare impacts (3 papers). Elliott Lever is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Genomics and Chromatin Dynamics (3 papers) and COVID-19 and healthcare impacts (3 papers). Elliott Lever collaborates with scholars based in United Kingdom, United States and Portugal. Elliott Lever's co-authors include Denise Sheer, David D’Cruz, Diego Ottaviani, Melanie Sloan, Rupert Harwood, Caroline Gordon, Stephen Sutton, Petros Takousis, Felix Naughton and James Brimicombe and has published in prestigious journals such as Nucleic Acids Research, Genome Research and Annals of the Rheumatic Diseases.

In The Last Decade

Elliott Lever

15 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elliott Lever United Kingdom 10 126 75 48 46 38 18 336
Bojana Brajenović‐Milić Croatia 15 79 0.6× 93 1.2× 31 0.6× 17 0.4× 57 1.5× 36 393
Rebecca Karp Leaf United States 11 110 0.9× 48 0.6× 59 1.2× 111 2.4× 15 0.4× 53 395
Lisa Beth Spiryda United States 11 108 0.9× 19 0.3× 43 0.9× 84 1.8× 74 1.9× 29 493
Maria Ibarra United States 10 64 0.5× 36 0.5× 73 1.5× 13 0.3× 20 0.5× 27 275
Laurence Belkoff United States 14 85 0.7× 45 0.6× 53 1.1× 89 1.9× 41 1.1× 66 574
Anette Kjærbye‐Thygesen Denmark 11 72 0.6× 14 0.2× 45 0.9× 94 2.0× 75 2.0× 22 431
Joanna Cobb United Kingdom 12 100 0.8× 37 0.5× 59 1.2× 7 0.2× 18 0.5× 18 392
Kathie P. Huang United States 12 89 0.7× 37 0.5× 65 1.4× 24 0.5× 7 0.2× 28 530
Saleem Khawaja Pakistan 6 46 0.4× 46 0.6× 148 3.1× 174 3.8× 26 0.7× 11 324
Ray Pais United States 9 46 0.4× 63 0.8× 42 0.9× 42 0.9× 122 3.2× 13 530

Countries citing papers authored by Elliott Lever

Since Specialization
Citations

This map shows the geographic impact of Elliott Lever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliott Lever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliott Lever more than expected).

Fields of papers citing papers by Elliott Lever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elliott Lever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliott Lever. The network helps show where Elliott Lever may publish in the future.

Co-authorship network of co-authors of Elliott Lever

This figure shows the co-authorship network connecting the top 25 collaborators of Elliott Lever. A scholar is included among the top collaborators of Elliott Lever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliott Lever. Elliott Lever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pollak, Thomas, David D’Cruz, Elliott Lever, et al.. (2025). A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial. Rheumatology International. 45(10). 233–233. 1 indexed citations
2.
Sloan, Melanie, Caroline Gordon, Thomas Pollak, et al.. (2025). ‘I still can’t forget those words’: mixed methods study of the persisting impact on patients reporting psychosomatic and psychiatric misdiagnoses. Lara D. Veeken. 64(6). 3842–3853. 3 indexed citations
3.
Lever, Elliott, et al.. (2023). P079 Use of an electronic text messaging service to improve efficiency in initial Fracture Liaison Service Patient Assessment. Lara D. Veeken. 62(Supplement_2). 1 indexed citations
4.
Lever, Elliott, et al.. (2022). Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence. Rheumatology Advances in Practice. 6(1). rkac009–rkac009.
5.
Sloan, Melanie, Caroline Gordon, Elliott Lever, et al.. (2021). COVID-19 and shielding: experiences of UK patients with lupus and related diseases. Rheumatology Advances in Practice. 5(1). rkab003–rkab003. 20 indexed citations
6.
Sloan, Melanie, Elliott Lever, Rupert Harwood, et al.. (2021). Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians. Lara D. Veeken. 61(6). 2262–2274. 53 indexed citations
7.
Lever, Elliott, et al.. (2021). Multifocal Mycobacterium kansasii osteomyelitis in a patient on ruxolitinib. Clinical Infection in Practice. 13. 100124–100124.
8.
Sloan, Melanie, Elliott Lever, Caroline Gordon, et al.. (2021). Medication decision-making and adherence in lupus: patient–physician discordance and the impact of previous ‘adverse medical experiences’. Lara D. Veeken. 61(4). 1417–1429. 17 indexed citations
9.
Sloan, Melanie, Rupert Harwood, Caroline Gordon, et al.. (2021). Will ‘the feeling of abandonment’ remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians. Lara D. Veeken. 61(9). 3723–3736. 6 indexed citations
10.
Lever, Elliott, et al.. (2020). <p>Towards Precision Medicine in Systemic Lupus Erythematosus</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 39–49. 25 indexed citations
11.
Sloan, Melanie, Caroline Gordon, Rupert Harwood, et al.. (2020). The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study. Rheumatology Advances in Practice. 5(1). rkaa072–rkaa072. 24 indexed citations
12.
Sloan, Melanie, Felix Naughton, Rupert Harwood, et al.. (2020). Is it me? The impact of patient–physician interactions on lupus patients’ psychological well-being, cognition and health-care-seeking behaviour. Rheumatology Advances in Practice. 4(2). 35 indexed citations
13.
Lever, Elliott, et al.. (2019). SAT0436 CROWNED-DENS SYNDROME: A RECENT CASE SERIES IN A SINGLE CENTRE IN THE UNITED KINGDOM. Annals of the Rheumatic Diseases. 78. 1307–1308.
14.
Laskou, Faidra, Gouri Koduri, Elliott Lever, Philip P. Stapleton, & Bhaskar Dasgupta. (2017). 335. FLARE RATES IN GIANT CELL ARTERITIS: A SINGLE-CENTRE LONG-TERM RETROSPECTIVE STUDY. Lara D. Veeken. 56(suppl_2). 1 indexed citations
15.
Ottaviani, Diego, Elliott Lever, Shihong Mao, et al.. (2012). CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma. Nucleic Acids Research. 40(12). 5262–5270. 11 indexed citations
16.
Lever, Elliott & Denise Sheer. (2009). The role of nuclear organization in cancer. The Journal of Pathology. 220(2). 114–125. 68 indexed citations
17.
Ottaviani, Diego, Elliott Lever, Richard Mitter, et al.. (2008). Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex. Genome Research. 18(11). 1778–1786. 22 indexed citations
18.
Ottaviani, Diego, Elliott Lever, Petros Takousis, & Denise Sheer. (2008). Anchoring the genome. Genome Biology. 9(1). 201–201. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bojana Brajenović‐Milić Breakdown of academic impact, for papers by Rebecca Karp Leaf Breakdown of academic impact, for papers by Lisa Beth Spiryda Breakdown of academic impact, for papers by Maria Ibarra Breakdown of academic impact, for papers by Laurence Belkoff Breakdown of academic impact, for papers by Anette Kjærbye‐Thygesen Breakdown of academic impact, for papers by Joanna Cobb Breakdown of academic impact, for papers by Kathie P. Huang Breakdown of academic impact, for papers by Saleem Khawaja Breakdown of academic impact, for papers by Ray Pais
Rankless by CCL
2026